Cite
McElroy AN, Invernizzi R, Laskowska JW, et al. Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2022;doi: 10.1164/rccm.202010-3880OC.
McElroy, A. N., Invernizzi, R., Laskowska, J. W., O'Neill, A., Doroudian, M., Moghoofei, M., Mostafaei, S., Li, F., Przybylski, A. A., O'Dwyer, D. N., Bowie, A. G., Fallon, P. G., Maher, T. M., Hogaboam, C. M., Molyneaux, P. L., Hirani, N., Armstrong, M. E., & Donnelly, S. C. (2022). Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. American journal of respiratory and critical care medicine, . https://doi.org/10.1164/rccm.202010-3880OC
McElroy, Aoife N, et al. "Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis." American journal of respiratory and critical care medicine vol. (2022). doi: https://doi.org/10.1164/rccm.202010-3880OC
McElroy AN, Invernizzi R, Laskowska JW, O'Neill A, Doroudian M, Moghoofei M, Mostafaei S, Li F, Przybylski AA, O'Dwyer DN, Bowie AG, Fallon PG, Maher TM, Hogaboam CM, Molyneaux PL, Hirani N, Armstrong ME, Donnelly SC. Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2022 Jan 05; doi: 10.1164/rccm.202010-3880OC. Epub 2022 Jan 05. PMID: 34985402.
Copy
Download .nbib